title: Klebsiella oxytoca bacteremia causing septic shock in recipients of hematopoietic stem cell transplant: Two case reports.
abstract: BACKGROUND
  Klebsiella oxytoca can cause various infectious complications in healthy as well as in immunocompromised individuals.
  
  
  METHODS
  Case 1: A 49 year old female with multiple myeloma received an autologous hematopoietic stem cell transplant in October 2005. Eight days following her autograft she developed septic shock caused by Klebsiella oxytoca bacteremia which was successfully treated with intravenous meropenem and gentamicin. Case 2: A 29 year old female with sickle cell anemia and severe aplastic anemia underwent an allogeneic hematopoietic stem cell transplant in July 2005. Seven months following her unsuccessful allograft, she developed septic shock due to Klebsiella oxytoca bacteremia caused by a urinary tract infection. The septic episode was successfully managed with intravenous meropenem and gentamicin. Both patients were treated at King Faisal Specialist Hospital and Research Centre in Riyadh, Saudi Arabia. To our knowledge, they are the first reports of Klebsiella oxytoca bacteremias and septic shocks in hematopoietic stem cell transplant recipients.
  
  
  CONCLUSIONS
  Klebsiella oxytoca should be considered as a possible cause of severe infections in recipients of various forms of hematopoietic stem cell transplantation. However, these infections may be complicated by bacteremias, septic shocks, systemic dysfunctions and even deaths if not managed promptly and appropriately.
authors.affiliation: Section of Adult Hematology and Hematopoietic, Stem Cell Transplant, King Faisal Cancer Centre, King Faisal Specialist Hospital and Research Centre, P,O, Box: 3345, Riyadh 11211, Saudi Arabia. kaa_alanazi@yahoo.com.
authors.forename: Khalid A
authors.initials: KA
authors.lastname: Al-Anazi
authors.forename: Asma M
authors.initials: AM
authors.lastname: Al-Jasser
authors.forename: Hazza A
authors.initials: HA
authors.lastname: Al-Zahrani
authors.forename: Naem
authors.initials: N
authors.lastname: Chaudhri
authors.forename: Fahad I
authors.initials: FI
authors.lastname: Al-Mohareb
references.citation: Infect Control Hosp Epidemiol. 2004 Oct;25(10):878-82
references.pmid: 15518033
references.citation: Pharmacotherapy. 2001 Aug;21(8):920-8
references.pmid: 11718498
references.citation: Acta Anaesthesiol Scand. 1992 Apr;36(3):289-91
references.pmid: 1574979
references.citation: Intern Med. 1998 Nov;37(11):990-4
references.pmid: 9868968
references.citation: Clin Infect Dis. 1997 Jun;24(6):1217-22
references.pmid: 9195086
references.citation: Infect Control Hosp Epidemiol. 2001 Mar;22(3):148-51
references.pmid: 11310692
references.citation: Infection. 1995 May-Jun;23(3):163-7
references.pmid: 7499005
references.citation: N Engl J Med. 2006 Dec 7;355(23):2418-26
references.pmid: 17151365
references.citation: Gastroenterol Clin Biol. 1994;18(2):181-2
references.pmid: 8013807
references.citation: Pathol Biol (Paris). 1999 May;47(5):405-7
references.pmid: 10418009
references.citation: J Antimicrob Chemother. 1991 Sep;28(3):389-97
references.pmid: 1960120
references.citation: Eur J Clin Microbiol Infect Dis. 2002 Jun;21(6):419-26
references.pmid: 12111596
references.citation: Arch Intern Med. 2005 Dec 12-26;165(22):2639-43
references.pmid: 16344422
references.citation: Antimicrob Agents Chemother. 1992 Dec;36(12):2639-44
references.pmid: 1482131
references.citation: Pediatr Infect Dis J. 2007 Feb;26(2):191-2
references.pmid: 17259891